Buy Lucetam (Piracetam) 1200mg

The drug is administered by mouth, during meals or on an empty stomach with some liquid.

Symptomatic treatment of psycho-organic syndrome: 2.4-4.8 g / day in 2-3 doses.

Treatment of vertigo and associated disorders of balance: 2.4-4.8 g / day in 2-3 doses.

Treatment of cortical myoclonus begin with a dose of 7.2 g / day every 3-4 days increase the dose of 4.8 g / d to a maximum dose of 24 g / day in 2-3 doses. The treatment is continued throughout the entire period of the disease. Every 6 months should attempt to reduce the dose or discontinuation of the drug, gradually reducing the dose of 1.2 g / day every 2 days.

Prevention of sickle cell vaso-occlusive crisis: the daily dose is 160 mg / kg body weight, divided into 4 equal doses.

Dyslexia treatment in children (in the complex therapy): The recommended daily dose for children aged 8 years and adolescents - 3.2 g divided into 2 doses.

For patients with impaired renal function dose should be adjusted depending on the value of KK.

CC may be calculated based on the concentration of serum creatinine by the following formula:

For male KK (ml / min) = [140 - age (years)] x body weight (kg) / 72 x serum creatinine (mg / dl);

QC for women can be calculated by multiplying the obtained value by a factor of 0.85.

Patients with renal failure requires correction dose preparation according to the following scheme.

kidney failure	CC (ml / min)	The dose and frequency of application
Norm	> 80	The usual dose
mild	50 - 79	2/3 usual dose is 2 - 3 doses
The average degree of	30 - 49	1/3 usual dose in 2 hours
severe	<30	1/6 usual dose once
final stage	<20	contraindicated

In patients of advanced age the dose is adjusted in the presence of renal failure; long-term therapy requires monitoring of renal function.

Patients with impaired liver function dose adjustment is required.

Patients with impaired renal function and liver, and the preparation is prescribed as well as for patients only with impaired renal function.

Nervous system: motor disinhibition (1.72%), spleen (1.13%), somnolence (0.96%), depression (0.83%), asthenia (0.23%); in rare cases - dizziness, headache, ataxia, balance disorder, aggravation of epilepsy, insomnia, confusion, agitation, anxiety, hallucinations, increased sexuality. In post-marketing practices observed following side effects, the frequency of which is not set (because of lack of data), headache, insomnia, agitation, imbalance, ataxia, aggravation of epilepsy, anxiety, hallucinations, confusion.

From the digestive system: nausea, vomiting, diarrhea, abdominal pain (including gastralgia).

Metabolism: weight gain (1.29%).

On the part of the organ of hearing and balance: vertigo.

For the skin: dermatitis, pruritus, urticaria.

Allergic reactions: angioneurotic edema, hypersensitivity, anaphylactic reactions.

Other: in rare cases - pain at the injection site, thrombophlebitis, pyrexia, hypotension (with on / in the introduction).

In most cases it is possible to achieve regression of these symptoms, lowering the dose of the drug.

- Psychomotor agitation at the time of drug administration;

- huntington's chorea;

- cerebrovascular accident (hemorrhagic stroke);

- the ultimate stage of chronic renal failure (with CC <20 ml / min);

- children up to 1 year (for oral solution);

- Children up to age 3 years (for tablets);

- increased sensitivity to the drug;

- Hypersensitivity to derivatives of pyrrolidone.

With caution should be used when drug abuse hemostasis, extensive surgery, severe bleeding, in patients with chronic renal failure (creatinine clearance of 20-80 ml / min).

In connection with the effect of piracetam on platelet aggregation caution should be prescribed to patients with impaired hemostasis during major surgery or in patients with symptoms of severe bleeding.

Abrupt interruption of treatment should be avoided in the treatment of cortical myoclonus, since it can cause a resumption of attacks.

In the treatment of sickle-cell anemia dose less than 160 mg / kg or irregular reception drug may cause an exacerbation of the disease.

When long-term therapy of elderly patients recommended the regular control indicators of renal function, when necessary, a correction of the dose according to the research results QC.

In the treatment of patients on giponatrievoy diet it is recommended to consider that piracetam oral solution at a dose of 24 g containing 80.5 mg of sodium.

Piracetam permeates through the membrane filter apparatus for hemodialysis.

Effects on ability to drive vehicles and management mechanisms

The treatment should be careful when driving and occupation of other potentially hazardous activities that require high concentration and psychomotor speed reactions.